Back

Can patient-derived iPSCs be applied to phenotypic cell-based high throughput screening assessment to distinguish between different types of long-QT syndrome?

28 August 2018 (11:00 - 11:15)
Organised by:
Congress Presentation Part of: Cardiac disease modelling Ion Channels, Electrophysiology ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Daisuke Yoshinaga

Boston Children's Hospital, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Electrically silent and stimulable iPSC-derived cardiomyocytes using RNA-guided epigenome editing
Professor J. Hulot (Paris, FR)
Abstract
Presentation thumbnail
Generation of disease specific iPSC-derived cardiomyocyte and investigation of their characteristics: study with clinically divergent female monozygotic twins with Danon disease.
Doctor S. Yoshida (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Exploring hypertrophic cardiomyopathy in iPSC-derived cardiomyocytes from patients with a novel autosomal recessive form of Noonan syndrome
Doctor L. Cyganek (Goettingen, DE)
Abstract
Presentation thumbnail
A novel platform to maintain adult cardiac tissue in vitro: myocardial slices and electromechanical stimulation with physiological preload
Mr S. Watson (London, GB)
Abstract Slides Video
Presentation thumbnail
Functional analysis of induced pluripotent stem cell-derived cardiomyocytes from patients with hypoplastic left heart syndrome in engineered heart tissues
Doctor Z. Zhang (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac disease modelling

The Event

Event poster

ESC Congress 2018

28 August 2018 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources